UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16
Under The Securities Exchange Act of 1934
For the month of June 2011
Commission File Number: 1-13064
NOVA Chemicals Corporation
1000 Seventh Avenue S.W., Calgary, Alberta, Canada, T2P 5L5
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
|
|
Form 20-F x |
Form 40-F o |
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
A copy of the Registrant’s Press Release dated June 29, 2011, NOVA Chemicals commits to growth in North America: “NOVA 2020”, is furnished herewith.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
NOVA Chemicals Corporation |
|
|
|
|
|
|
|
|
/s/ Ronald E.J. Kemle |
|
|
Ronald E.J. Kemle |
|
|
Vice President and Deputy General Counsel |
|
|
|
|
|
|
|
June 29, 2011 |
|